15.06.2010 • NewsDSMLawsuitKautschuk

DSM Announces Settlement Of Federal Class Antitrust Litigation

A class of businesses that purchased ethylene proplylene diene monomer (EPDM) between 1997 and 2001 has reached agreement with two subsidiaries of Royal DSM to settle a long-running antitrust dispute before trial in return for a payment of $25 million.

The EPDM class action, pending in the U.S. District Court for the District of Connecticut, was vigorously litigated by both sides; the DSM defendants consistently denied any wrongdoing in connection with the allegations. In 2006, competition enforcement authorities in the EU, U.S. and Canada concluded their EPDM investigations without bringing any charges against DSM or any of its employees. The DSM defendants have now entered into the settlement to eliminate the burden, expense and risk of further litigation. The proposed class action settlement is subject to Court approval.

If approved, and following due notice to the class members, the class action will be dismissed with prejudice and all claims asserted in the class action against the DSM defendants will be released.

 

Company

Royal DSM N.V.


6401 JH Heerlen

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.